Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose Alvir

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Orphanet Journal of Rare Diseases|February 27, 2025
Clinical and economic burden of achondroplasia in the United States: results from a retrospective, observational studyNadia Merchant, Jose Alvir, Paulette Negron Ericksen, et al.
Kidney International Reports|October 8, 2021
A Retrospective Study of Clinical and Economic Burden of Focal Segmental Glomerulosclerosis (FSGS) in the United StatesKamyar Kalantar-Zadeh, Christine L Baker, J Brian Copley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 22, 2024
Multiyear, real-world, retrospective cohort study using a patient-centric approach to evaluate the burden of haemophilia B in the United StatesArianna Burton, Yong Chen, Priya Patel, et al.
The American Journal of Managed Care|October 13, 2009
Effects of a Medicaid prior authorization policy for pregabalinJay M Margolis, Stephen S Johnston, Bong-Chul Chu, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2022
The economic burden of Parkinson disease among Medicare beneficiariesHusam Albarmawi, Shujia Zhou, Lisa M Shulman, et al.
Neurology|May 28, 2021
Health Care Resource Utilization Associated With Parkinson Disease Among Medicare BeneficiariesAakash Bipin Gandhi, Eberechukwu Onukwugha, Husam Albarmawi, et al.
Biological Psychiatry|May 15, 2002
Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjectsHandan Gunduz, Huwei Wu, Manzar Ashtari, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 13, 2023
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United StatesRahul Bhambri, A Carmine Colavecchia, Marianna Bruno, et al.
BJU International|November 17, 2009
Patient-reported reasons for discontinuing overactive bladder medicationJoshua S Benner, Michael B Nichol, Eric S Rovner, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorderKaren L Rascati, Kristin M Richards, Carol A Ott, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Orphanet Journal of Rare Diseases|February 27, 2025
Clinical and economic burden of achondroplasia in the United States: results from a retrospective, observational studyNadia Merchant, Jose Alvir, Paulette Negron Ericksen, et al.
Kidney International Reports|October 8, 2021
A Retrospective Study of Clinical and Economic Burden of Focal Segmental Glomerulosclerosis (FSGS) in the United StatesKamyar Kalantar-Zadeh, Christine L Baker, J Brian Copley, et al.
Haemophilia : the Official Journal of the World Federation of Hemophilia|July 22, 2024
Multiyear, real-world, retrospective cohort study using a patient-centric approach to evaluate the burden of haemophilia B in the United StatesArianna Burton, Yong Chen, Priya Patel, et al.
The American Journal of Managed Care|October 13, 2009
Effects of a Medicaid prior authorization policy for pregabalinJay M Margolis, Stephen S Johnston, Bong-Chul Chu, et al.
Journal of Managed Care & Specialty Pharmacy|March 25, 2022
The economic burden of Parkinson disease among Medicare beneficiariesHusam Albarmawi, Shujia Zhou, Lisa M Shulman, et al.
Neurology|May 28, 2021
Health Care Resource Utilization Associated With Parkinson Disease Among Medicare BeneficiariesAakash Bipin Gandhi, Eberechukwu Onukwugha, Husam Albarmawi, et al.
Biological Psychiatry|May 15, 2002
Basal ganglia volumes in first-episode schizophrenia and healthy comparison subjectsHandan Gunduz, Huwei Wu, Manzar Ashtari, et al.
American Journal of Cardiovascular Drugs : Drugs, Devices, and Other Interventions|February 13, 2023
Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United StatesRahul Bhambri, A Carmine Colavecchia, Marianna Bruno, et al.
BJU International|November 17, 2009
Patient-reported reasons for discontinuing overactive bladder medicationJoshua S Benner, Michael B Nichol, Eric S Rovner, et al.
Psychiatric Services (Washington, D.C.)|September 3, 2011
Adherence, persistence of use, and costs associated with second-generation antipsychotics for bipolar disorderKaren L Rascati, Kristin M Richards, Carol A Ott, et al.
Pageof 6